Carregant...
Immunotherapy in Genitourinary Malignancies
PURPOSE OF REVIEW: Active investigation suggests immune checkpoint inhibitor therapy and therapeutic cancer vaccines provide clinical benefit for genitourinary (GU) malignancies including prostate cancer, renal cell carcinoma (RCC) and bladder cancer. Recent developments in the utility of immune che...
Guardat en:
| Publicat a: | Curr Opin Urol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5129842/ https://ncbi.nlm.nih.gov/pubmed/27471994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOU.0000000000000331 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|